Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maham Doagooyan
Institution:
Mashhad University of Medical Sciences
Observed institutions:
Pasteur Institute of Iran,
Mashhad University of Medical Sciences
ORCID:
0000-0003-2962-571X
Observed ORCID:
0000-0003-2962-571X
OpenAlex ID:
A5020614613
Ellagic acid nanoliposomes potentiate therapeutic effects of PEGylated liposomal doxorubicin in melanoma: An in vitro and in vivo study
2024
·
Fatemeh Heidarian
, Seyedeh Hoda Alavizadeh
, et al.
·
Journal of Drug Delivery Science and Technology
·
25
Alleviation of acetaminophen-induced liver failure using silibinin nanoliposomes: An in vivo study
2023
·
Fatemeh Gheybi
, Alireza Khooei
, et al.
·
Biochemical and Biophysical Research Communications
·
19
Harnessing aptamers against COVID-19: A therapeutic strategy
2023
·
Ali Mahmoudi
, Seyedeh Hoda Alavizadeh
, et al.
·
Drug Discovery Today
·
19
PDF
Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID‐19
2022
·
Seyedeh Hoda Alavizadeh
, Maham Doagooyan
, et al.
·
IET Nanobiotechnology
·
8
Anti-tumor activity of silymarin nanoliposomes in combination with iron: In vitro and in vivo study
2023
·
Maham Doagooyan
, Seyedeh Hoda Alavizadeh
, et al.
·
International Journal of Pharmaceutics X
·
5
COVID-19 therapy approaches and vaccine development: the role of nanotechnology
2021
·
Maham Doagooyan
, Seyedeh Hoda Alavizadeh
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
·
2
Coronavirus Disease 2019 (Covid-19) in Middle East: Data, Facts and Doubts
2020
·
Majid Rajabian
, Maham Doagooyan
·
International journal of pediatrics
·
2
Investigation of Structural, Treatment, and Clinical Characteristics of COVID-19 Along with the Challenges Caused by its Prevalence
2021
·
Maham Doagooyan
, Seyedeh Hoda Alavizadeh
, et al.
·
Infectious Disorders - Drug Targets
Show more works
View as search
Works count:
8
Citation count:
80
H-index:
5
I10-index:
3
Year
Topic
Type